| Product Code: ETC4642279 | Publication Date: Nov 2023 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 60 | No. of Figures: 30 | No. of Tables: 5 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ireland Infectious Disease Biomarker Testing Market Overview |
3.1 Ireland Country Macro Economic Indicators |
3.2 Ireland Infectious Disease Biomarker Testing Market Revenues & Volume, 2021 & 2031F |
3.3 Ireland Infectious Disease Biomarker Testing Market - Industry Life Cycle |
3.4 Ireland Infectious Disease Biomarker Testing Market - Porter's Five Forces |
3.5 Ireland Infectious Disease Biomarker Testing Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Ireland Infectious Disease Biomarker Testing Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.7 Ireland Infectious Disease Biomarker Testing Market Revenues & Volume Share, By End-users, 2021 & 2031F |
4 Ireland Infectious Disease Biomarker Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of infectious diseases in Ireland |
4.2.2 Growing awareness about the importance of early disease detection |
4.2.3 Technological advancements in biomarker testing leading to more accurate and efficient diagnosis |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for biomarker testing |
4.3.2 Limited access to advanced biomarker testing technologies in certain regions of Ireland |
4.3.3 High costs associated with biomarker testing leading to affordability issues for some patients |
5 Ireland Infectious Disease Biomarker Testing Market Trends |
6 Ireland Infectious Disease Biomarker Testing Market Segmentations |
6.1 Ireland Infectious Disease Biomarker Testing Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Ireland Infectious Disease Biomarker Testing Market Revenues & Volume, By Assays, Kits and Reagents, 2021-2031F |
6.1.3 Ireland Infectious Disease Biomarker Testing Market Revenues & Volume, By Instruments, 2021-2031F |
6.1.4 Ireland Infectious Disease Biomarker Testing Market Revenues & Volume, By Services and Software, 2021-2031F |
6.2 Ireland Infectious Disease Biomarker Testing Market, By Technology |
6.2.1 Overview and Analysis |
6.2.2 Ireland Infectious Disease Biomarker Testing Market Revenues & Volume, By Immunodiagnostics, 2021-2031F |
6.2.3 Ireland Infectious Disease Biomarker Testing Market Revenues & Volume, By Clinical Microbiology, 2021-2031F |
6.2.4 Ireland Infectious Disease Biomarker Testing Market Revenues & Volume, By PCR, 2021-2031F |
6.2.5 Ireland Infectious Disease Biomarker Testing Market Revenues & Volume, By INAAT, 2021-2031F |
6.2.6 Ireland Infectious Disease Biomarker Testing Market Revenues & Volume, By DNA Sequencing and NGS, 2021-2031F |
6.2.7 Ireland Infectious Disease Biomarker Testing Market Revenues & Volume, By Other Technologies, 2021-2031F |
6.3 Ireland Infectious Disease Biomarker Testing Market, By End-users |
6.3.1 Overview and Analysis |
6.3.2 Ireland Infectious Disease Biomarker Testing Market Revenues & Volume, By Physician Offices, 2021-2031F |
6.3.3 Ireland Infectious Disease Biomarker Testing Market Revenues & Volume, By Reference Laboratories, 2021-2031F |
6.3.4 Ireland Infectious Disease Biomarker Testing Market Revenues & Volume, By Hospitals, 2021-2031F |
6.3.5 Ireland Infectious Disease Biomarker Testing Market Revenues & Volume, By Academic and Research Institutes, 2021-2031F |
6.3.6 Ireland Infectious Disease Biomarker Testing Market Revenues & Volume, By Others, 2021-2031F |
7 Ireland Infectious Disease Biomarker Testing Market Import-Export Trade Statistics |
7.1 Ireland Infectious Disease Biomarker Testing Market Export to Major Countries |
7.2 Ireland Infectious Disease Biomarker Testing Market Imports from Major Countries |
8 Ireland Infectious Disease Biomarker Testing Market Key Performance Indicators |
8.1 Percentage increase in the number of infectious disease biomarker tests conducted annually |
8.2 Adoption rate of new biomarker testing technologies in healthcare facilities |
8.3 Average turnaround time for infectious disease biomarker test results |
8.4 Rate of successful treatment outcomes correlated with early detection through biomarker testing |
8.5 Percentage of healthcare professionals trained in interpreting biomarker test results |
9 Ireland Infectious Disease Biomarker Testing Market - Opportunity Assessment |
9.1 Ireland Infectious Disease Biomarker Testing Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Ireland Infectious Disease Biomarker Testing Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.3 Ireland Infectious Disease Biomarker Testing Market Opportunity Assessment, By End-users, 2021 & 2031F |
10 Ireland Infectious Disease Biomarker Testing Market - Competitive Landscape |
10.1 Ireland Infectious Disease Biomarker Testing Market Revenue Share, By Companies, 2024 |
10.2 Ireland Infectious Disease Biomarker Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations | 13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here